Limited coverage drugs – meloxicam

Last updated on August 23, 2024

Generic name

meloxicam

Strength

7.5 mg, 15 mg

Form

tablet

Special Authority criteria

Approval period

For the treatment of patients who have a:

  • Diagnosis of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, gout or lupus

OR

  • Treatment failure on optimal doses of, or intolerance to, both ibuprofen and naproxen.

Indefinite

Practitioner exemptions

Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:

  • Paediatrics
  • Paediatric cardiology
  • Paediatric general surgery
  • Physical medicine and rehabilitation
  • Rheumatology

Special notes

  • Treatment failure on, or intolerance to, the specific medications listed in the above criteria is required.

Special Authority request form(s)